Joseph Spanier
Medical · Philadelphia, PANPI 1669536710
Payments from drug & device makers
Across 86 payments — averaging $20.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$269
- Insmed, Inc.$156
- GSK$154
- Mallinckrodt Hospital Products Inc.$120
- Jazz Pharmaceuticals Inc.$106
- Novo Nordisk$105
- plus $812 from 20 others
What the payments were for
- Food & beverage$1,721100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 16 | $269 |
| Insmed, Inc. | 6 | $156 |
| GSK | 9 | $154 |
| Mallinckrodt Hospital Products Inc. | 4 | $120 |
| Jazz Pharmaceuticals Inc. | 5 | $106 |
| Novo Nordisk | 6 | $105 |
| Boehringer Ingelheim | 4 | $101 |
| Bayer | 5 | $101 |
| Sanofi-aventis U.S. LLC | 4 | $73 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $65 |
| Harmony Biosciences LLC | 2 | $54 |
| AbbVie | 2 | $54 |
| Abbott | 2 | $46 |
| Teva Pharmaceuticals USA, Inc. | 3 | $44 |
| Exact Sciences | 2 | $39 |
| Mylan Specialty L.p. | 2 | $34 |
| Vapotherm Inc | 2 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Fidia Pharma USA Inc. | 1 | $23 |
| Vertos Medical, Inc. | 1 | $21 |
| Intuity Medical Inc | 1 | $19 |
| Linus Health, Inc. | 1 | $18 |
| Advanced Respiratory, Inc | 1 | $16 |
| Amgen | 1 | $16 |
| Pfizer | 1 | $15 |
| Tactile Systems Technology Inc | 1 | $14 |
How this compares
$1,721 in reported general payments places this provider in the 75th percentile of 2,594 medical providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 60 | $59,181 |
| JardianceEmpagliflozin | 18 | $17,503 |
| XareltoRivaroxaban | 16 | $11,413 |
| Spiriva RespimatTiotropium Bromide | 12 | $8,126 |
| Atorvastatin Calcium | 237 | $3,435 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 18 | $3,399 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $2,674 |
| Fluoxetine Hcl | 28 | $1,921 |
| SynthroidLevothyroxine Sodium | 24 | $1,830 |
| Lisinopril | 179 | $1,693 |
| Eszopiclone | 15 | $1,678 |
| Novolog FlexpenInsulin Aspart | 12 | $1,626 |
| Losartan Potassium | 106 | $1,488 |
| Levothyroxine Sodium | 90 | $1,088 |
| Simvastatin | 112 | $1,077 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $15 | $59,18160 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $101 | $25,62930 claims |
| AstraZenecaSymbicort | $269 | $2,67412 claims |
| AbbVieSynthroid | $54 | $1,83024 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,594 medical providers in Pennsylvania.
Other medical in Philadelphia
- Angela KapalkoPhiladelphia$123K
- Linda PerryPhiladelphia$123K
- Sarah SmithPhiladelphia$65K
- Victoria WongPhiladelphia$51K
- Parth PatelPhiladelphia$46K
- Zachary LutzPhiladelphia$30K
- Hawah MusaPhiladelphia$13K
- Carl BlackPhiladelphia$13K
- Ashley BarratPhiladelphia$12K
- Jacqueline KernaghanSpringfield$427K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.